Clinical Manifestations

Area of Science:

• Neuroscience
• Gerontology
• Psychiatry

Background:

• Cognitive reserve (CR) mitigates cognitive decline in neurodegenerative diseases like Alzheimer's (AD).
• The relationship between CR and neuropsychiatric symptoms (NPS) in neurodegenerative conditions is less understood.
• AD-related brain atrophy, particularly in the hippocampus and entorhinal cortex, is linked to NPS.

Purpose of the Study:

• To investigate the moderating effect of CR on the association between hippocampal and entorhinal cortex atrophy and NPS in older adults.
• To determine if CR influences the manifestation of NPS in the presence of neurodegenerative brain changes.

Main Methods:

• Utilized data from 455 participants in the COMPASS-ND study with varying cognitive statuses.
• Calculated a composite CR score (CRS) from education, occupation, and personal activities.
• Employed logistic regression to model the relationship between hippocampal/entorhinal atrophy and NPS, testing for CRS interaction effects.

Main Results:

• Higher CRS correlated with better cognitive scores (MoCA) and lower likelihood of NPS.
• Significant evidence indicated that hippocampal atrophy was less associated with NPS in individuals with higher CR.
• A similar trend was observed for entorhinal atrophy, though not statistically significant.

Conclusions:

• Elevated cognitive reserve can buffer the impact of hippocampal atrophy on neuropsychiatric symptoms, independent of overall cognition.
• These findings suggest CR offers protective benefits that extend beyond cognitive function to behavioral outcomes.
• Further longitudinal research is recommended to explore domain-specific CR effects and functional imaging correlates.